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Abstract 
 
Background: Nowadays, there has been an increase in the number of studies focused on the search for bioactive 
compounds produced by hydrolytic reactions from natural sources, such as the Quinoa grain, which represents an 
interesting agro-alimentary source that can have a beneficial influence on health, specifically antihypertensive potential. For 
this reason, the aim of the present study was to evaluate the antihypertensive activity of the protein hydrolysates obtained of 
Quinoa, the results of which are important at that time, to consider the incorporation of such peptides in the design of 
functional foods. 
Materials and Methods: Quinoa (Chenopodium quinoa Willd.) seeds were ground and the obtained flour was degreased 
and the protein isolate was obtained by isoelectric precipitation. The protein isolate was enzymatically hydrolyzed with 
Alcalase® and Flavourzyme® and the antihypertensive effect of peptides against angiotensin converting enzyme was 
evaluate using a mixture of 50 µL of sample, 50 µL of ACE working solution, 200 µL of substrate working solution and the 
fluorescence was determined with a microplate fluorometer following these characteristics: λ (excitation) = 355-375 nm; λ 
(emission) = 400-430 nm. 
Results: Peptides obtained using Alcalase® (protein content= 72.13%; DH= 31.22%) showed the highest inhibitory 
activity against the angiotensin converting enzyme (ACE), close to 88%.  
Conclusion: The Quinoa protein hydrolysates can be considered as a new agri-food source to be incorporated in the 
elaboration of functional foods with antihypertensive potential. 
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Abbreviations: ACE: Angiotensin converting enzyme, AU: Anson unit, LAPU: Leucine aminopeptidase unit, DH: Degree 
of hydrolysis, TNBS: 2,4,6-trinitrobenzenesulfonic acid, SDS-PAGE: Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis, ANOVA: Analysis of variance. 
 
 
Introduction 
 
 Quinoa (Chenopodium quinoa Willd.) from the Chenopodiaceae family is a pseudocereal that has been cultivated 
for thousands of years in the andean region of South America (Jancurová et al., 2009; Galvez-Ranilla et al., 2009). This 
grain counts with an exceptional nutritional value and is considered one of the best vegetable protein sources, as its protein 
levels are higher than those present in cereals. Besides, it contains all essential amino acids and is gluten-free by nature 
(González-Martín et al., 2014; Vega-Gálvez et al., 2010).  
 In recent years, there has been an increase in the number of studies focused on the search for bioactive compounds 
from natural sources that can be usable and incorporated as an alimentary substitute, as well as the elaboration of functional 
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foods (Rastogi and Shukla, 2013). A wide range of agro resources, provide a rich source of bioactive peptides after 
gastrointestinal digestion. It has been demonstrated that these peptides present biological activity, such as the inhibition of 
the activity of the angiotensin converting enzyme (ACE), the principal causing agent of the hypertension, which is one of  
the most widespread chronic diseases in developed countries (Matsui et al., 1993; Kim et al., 2001; Wu and Ding, 2001). 
For this reason, Quinoa grain represents an interesting agro-alimentary source that can be modified chemically to provide 
improvements in its biofunctional properties, specifically for the treatment of hypertension. 
 Therefore, considering the degree of hydrolysis influences the bio- and techno- functional properties of the 
peptides, the aim of the present study was to evaluate the antihypertensive activity (inhibition of the angiotensin I 
converting enzyme) of the protein hydrolysates obtained of Quinoa, the results of which are important at the time, to 
consider the incorporation of such peptides in the design of functional foods. 
 
Materials and Methods 
 
 Quinoa (Chenopodium quinoa Willd.) seeds were obtained from Vizana Nutrition Company (Monclova, Coahuila, 
México). The seeds were ground and the obtained flour was degreased by extraction with hexane for 9 h in a Soxhlet 
extraction unit. The defatted meal (0.25% ± 0.03 crude fat, dry matter basis) was stored in hermetically sealed containers at 
4°C until use.  
 
Obtention and Enzymatic Hydrolysis of Protein Isolates 
 
 The protein isolate was prepared as previously described by Vioque et al. (1999). It was produced by suspending 
1000 mg of quinoa defatted meal in water (1:10, w/v) with Na2SO3 (0.25 %, w/v) at pH 10.5. The suspension was stirred 
for 1 h at 25°C then centrifuged for 25 min at 8500 rpm at 4°C; the protein in the supernatant was precipitated at pH 4.5. 
The protein isolate was hydrolyzed with Alcalase® and Flavourzyme® under the following parameters: substrate 
concentration, 5%; enzyme/substrate ratio, 0.3 AU g-1 for Alcalase® and 50 LAPU g-1 for Flavourzyme®; pH, 7 for 
Alcalase® and 8 for Flavourzyme®; temperature, 50 °C; hydrolysis time, 60 min. Degree of hydrolysis (DH) was 
calculated by determining free amino groups with 2,4,6-trinitrobenzenesulfonic acid (TNBS) following Adler-Nissen 
(1979). These enzymatic treatments will allow the obtaining of hypoallergenic hydrolysates. 
 
Protein quantification 
 
 Total nitrogen was determined by combustion according to Dumas (1831) procedure and converted to crude 
protein considering that all the nitrogen is in raw using a conversion factor (AOAC, 1997).  
 
 
SDS-PAGE of Quinoa Protein Fractions 
 
 Protein profile of Quinoa was carried out by SDS-PAGE with 5% stacking gel and 15% of separating gel and a 
standard protein marker (250-10 kDa) was used as molecular weight standard.  
 
Determination of Molecular Weight Distribution of Bioactive Peptides 
 
 Molecular weights were analyzed by gel filtration chromatography using a molecular exclusion column monitoring 
at an absorbance of 280 nm.  
 
ACE inhibitory activity 
 
 The inhibitory effect of peptides against angiotensin converting enzyme, were evaluated according to Sentandreu 
and Toldra (2006). The angiotensin converting enzyme inhibition was calculated using the following equation: 
 
Inhibitory peptides concentration (%) 
 
= 100 [(Fluorescencecontrol – Fluorescenceblank) – (FluorescenceB sample – Fluorescencesample) / Fluorescencecontrol – 
Fluorescenceblank)] 
 
Statistical analysis 
 
 The collected data were analyzed using the statistical software IBM SPSS Statistics 20®. Statistical comparisons of 
mean values for each experiment were performed using a single ANOVA, followed by a Tukey test (P < 0.05).  
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Results and Discussion 
 
 The hydrolysates obtained from Chenopodium quinoa Willd. showed a 72.13±0.44% protein content, with a 
degree of hydrolysis of 31.22%, and the electrophoresis patterns are shown in Figure 1.  
 
Figure 1: SDS-PAGE of C. quinoa Willd. 
 
As a consequence of the hydrolysis, fractions of 15-10 kDa begin to be perceived (lane 2). Extensive hydrolysis may result 
in the formation of shorter peptides that can make their detection difficult on SDS-PAGE, hence the reason why the 
molecular weight of the protein hydrolysate was determined by gel filtration chromatography (Figure 2).  
 
Figure 2: Molecular weight distribution of C. quinoa Willd. 
 
 The chromatogram showed three chromatographic peaks with molecular weights of 4.25 kDa, 2.71 kDa and 1.11 
kDa. These results anticipating the presence of peptides in which the inhibitory activity of the angiotensin converting 
enzyme can be evaluated (Figure 3). 
 The influence exerted by the type of enzyme used during the hydrolysis on the inhibitory capacity of the 
angiotensin converting enzyme can be clearly seen. The action of Alcalase® and Flavourzyme® differed significantly 
(p<0.01) due to the different times of hydrolysis in the inhibition of ACE. The highest values are those shown the 
hydrolysates obtained with Alcalase®, which are around 80-90%, while the most deficient values are those exhibited with 
Flavourzyme®, ranging from 40-50%. 
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 These results are very similar to those described by Aluko and Monu (2003), who observed that the reduction of 
peptide size significantly increases the ability of the hydrolysate to inhibit ACE activity, reporting values ranging from 15 
to 10% of residual activity using Alcalase®. This suggests that the low molecular weight peptides of Quinoa could be 
easily absorbed by the body, which results in a promising effect that helps to counteract health problems and the possibility 
of being incorporated as a food substitute in the formulation of functional foods.   
 
0
10
20
30
40
50
60
70
80
90
100
Alcalase Flavourzyme Alcalase Flavourzyme Alcalase Flavourzyme Alcalase Flavourzyme Alcalase Flavourzyme
0 15 30 45 60
In
hi
bi
to
ry
 a
ct
iv
ity
 (
%
)
Hydrolysis time (min)  
 
Figure 3: ACE inhibitory activity of Quinoa hydrolysates 
 
Conclusions 
 
 Quinoa bioactive peptides with molecular weights between 1 and 5 kDa obtained with Alcalase® showed a high 
potential to act as angiotensin converting enzyme inhibitors, besides to the advantage of its hypoallergenic character, which 
suggests that these peptides can be considered to be incorporated in the elaboration of functional foods. 
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